Task: Answer the multiple-choice question.
Question: Which drug has a -14.811% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) CCCCN(CCCC)C(=O)c1nsnc1-c1ccccc1O
(b) CSc1ccc(S(=O)(=O)N2CCC(C(=O)NC3CCCCC3)CC2)cc1
(c) Cc1ccc(C)c(S(=O)(=O)N2CCN(CC(=O)Nc3ccc4c(c3)OCCO4)CC2)c1
(d) CCC(=O)NC(C)c1cc(Cl)c2cccnc2c1O
Answer: a. CCCCN(CCCC)C(=O)c1nsnc1-c1ccccc1O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CCCC)C(=O)c1nsnc1-c1ccccc1O
CCCCN(CCCC)C(=O)c1nsnc1-c1ccccc1O
N,N-dibutyl-4-(2-hydroxyphenyl)-1,2,5-thiadiazole-3-carboxamide